首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >In vitro transdermal iontophoretic delivery of leuprolide under constant current application
【24h】

In vitro transdermal iontophoretic delivery of leuprolide under constant current application

机译:恒流下亮丙瑞林的体外透皮离子电渗疗法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Transdermal delivery of Leuprolide, a nonapeptide LHRH agonist, was studied using constant current iontophoresis to explore methods for improving iontophoretic efficiency and determine the feasibility of delivery of therapeutic doses of the drug. Universal buffer consisting of citrate, phosphate and berate was used to carry out in vitro permeation experiments with heat separated human epidermis at pH 4.5 and 7.2. In addition, the effect of substituting this buffer with a macromolecular electrolyte, polymaleic acid, on the drug flux and the transference number was studied. Current densities from 0.5 to 2.3 muA cm(2) were used requiring moderate potential differences between 60 and 420 mV to be applied thus limiting irreversible epidermal membrane alterations. The rather high electrical resistance of the epidermis of the order of 200 kOmega cm(2) was related to the sub-physiological electrolyte concentration. Resistance was continuously monitored to guarantee barrier integrity of the membrane. The permeation rate increased linearly with the current density for the universal buffer and was at pH 7.2 almost double that at pH 4.5 despite the greater ionic valence of the drug at pH 4.5 compared to pH 7.2; this being because of the opposite direction of the electroosmotic flow at the two pH values. Drug transference number at both pH values was approximately 0.5%. Replacement of the universal buffer with polymaleic acid yielded higher drug permeation rates and increased its transference number at comparable pH. Transference number, however, was still approximately 1% at the highest current density, showing that concomitant ions from added electrolyte or extracted from the skin and the electrodes accounted for 99% of the total current. Further, transference number of the drug with polymaleic acid appeared to increase with current density. The fluxes obtained for both electrolyte systems with the present experimental arrangement could be extrapolated to deliver therapeutically relevant doses of the drug. (C) 2004 Elsevier B.V. All rights reserved.
机译:使用恒定电流离子电渗疗法研究了非肽LHRH激动剂亮丙瑞林的透皮给药,以探索提高离子电渗效率的方法,并确定了治疗剂量药物的可行性。使用由柠檬酸盐,磷酸盐和贝酸盐组成的通用缓冲液,以pH 4.5和7.2的热分离人表皮进行体外渗透实验。另外,研究了用高分子电解质聚马来酸代替该缓冲液对药物通量和转移数的影响。使用的电流密度为0.5到2.3μAcm(2),需要施加60到420 mV之间的中等电位差,因此限制了不可逆的表皮膜改变。表皮的相当高的电阻约为200 kOmega cm(2)与亚生理电解质浓度有关。连续监测电阻以确保膜的屏障完整性。渗透速率随通用缓冲液的电流密度线性增加,在pH 7.2时几乎达到pH 4.5的两倍,尽管在pH 4.5时药物的离子价比pH 7.2高。这是因为在两个pH值下电渗流的方向相反。在两个pH值下的药物转移数均为约0.5%。用聚马来酸代替通用缓冲液可产生更高的药物渗透速率,并在相当的pH值下增加其转移数。但是,在最高电流密度下,迁移率仍约为1%,这表明来自添加的电解质或从皮肤和电极中提取的伴随离子占总电流的99%。此外,药物与聚马来酸的转移数似乎随着电流密度而增加。可以推断出具有本实验装置的两种电解质系统所获得的通量以递送治疗上相关剂量的药物。 (C)2004 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号